Table 4.
Dates | Mean (95% CI) | Number of patients | |
---|---|---|---|
Baseline | February 14–March 14, 2018 | 15.8% (11.8%, 19.9%) | 316 |
March 15–April 10, 2018 | 17.5% (13.3%, 21.8%) | 302 | |
April 11–May 8, 2018 | 15.1% (11.3%, 18.9%) | 338 | |
May 9–June 5, 2018 | 16.1% (12.1%, 20.2%) | 322 | |
February 14–June 5, 2018 | 16.1% (14.1%, 18.1%) | 1278 | |
Most recent | July 3–July 30, 2019 | 16.3% (11.1%, 21.6%) | 190 |
July 31–August 27, 2019 | 23.0% (16.9%, 29.2%) | 178 | |
August 28–September 24, 2019 | 24.2% (17.3%, 31.0%) | 149 | |
September 25–October 22, 2019 | 22.1% (15.7%, 28.5%) | 163 | |
July 3–October 22, 2019 | 21.2% (18.1%, 24.3%) | 680 |
(Top) CW compliance, mean (95% CI), at baseline for each of the first four 4-week intervals prior to nudge launch in the Vanguard sites and overall baseline CW compliance rate across all 16 weeks. (Bottom) CW compliance, mean (95% CI), in the most recent four 4-week intervals after nudge deployment at all five practices, as well as the overall postintervention CW compliance rate across all 16 weeks